Childhood cancer: incidence and early deaths in Argentina, 2000-2008

Florencia Moreno1, Dora Loria, Graciela Abriata

  • 1Argentinean Oncopediatric Registry, National Cancer Institute, Buenos Aires City, Argentina. roha@roha.org.ar

European Journal of Cancer (Oxford, England : 1990)
|September 18, 2012
PubMed

Insights

Childhood cancer incidence in Argentina is lower than in North America and Western Europe, with no increase observed. Early deaths suggest challenges in cancer care organization.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Public Health

Background:

  • Limited data exists on childhood cancer epidemiology in Latin America.
  • The Argentinean Oncopaediatric Registry (ROHA) has collected data since 2000.
  • This study analyzes ROHA data from 2000-2008.

Purpose of the Study:

  • To describe the epidemiology of childhood cancer in Argentina.
  • To establish incidence rates and common cancer types.
  • To identify areas for improving childhood cancer care.

Main Methods:

  • Utilized data from the Argentinean Oncopaediatric Registry (ROHA).
  • Included cases from paediatric units and population-based cancer registries.
  • Classified cancers using the International Classification of Childhood Cancer.

Main Results:

  • 11,447 childhood cancer cases (ages 0-14) were reported.
  • The standardized incidence rate was 128.5 per million; leukaemias (37%), CNS tumors (18%), and lymphomas (13%) were most common.
  • Leukemia incidence peaked around age 3; 80% of patients used public hospitals, and 35% migrated for treatment.

Conclusions:

  • Childhood cancer incidence in Argentina is lower than in North America/Western Europe, mainly due to CNS and other solid tumors.
  • No increasing trend in childhood cancer incidence was observed.
  • High early mortality rates indicate suboptimal organization of childhood cancer care.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...